MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 61 filers reported holding MENLO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $250,000 | +35.1% | 53,851 | +30.7% | 0.21% | +50.4% |
| Q3 2019 | $185,000 | +96.8% | 41,188 | +161.1% | 0.14% | +139.7% |
| Q2 2019 | $94,000 | -82.1% | 15,775 | -76.5% | 0.06% | -73.1% |
| Q1 2019 | $526,000 | -25.9% | 66,996 | -61.1% | 0.22% | -27.5% |
| Q4 2018 | $710,000 | – | 172,433 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners L.P. | 1,461,552 | $11,868,000 | 12.24% |
| Vivo Capital, LLC | 4,011,236 | $32,571,000 | 4.20% |
| DAFNA Capital Management LLC | 312,000 | $2,533,000 | 1.19% |
| Novo Holdings A/S | 1,436,313 | $11,663,000 | 1.17% |
| Perceptive Advisors | 1,241,287 | $10,079,000 | 0.26% |
| Rock Springs Capital Management LP | 330,000 | $2,680,000 | 0.10% |
| Baker Brothers Advisors | 700,000 | $5,684,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 50,000 | $406,000 | 0.02% |
| A.R.T. Advisors, LLC | 31,703 | $257,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 2,036,111 | $16,533,000 | 0.01% |